EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
about
Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressorMediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligaseRegulation of apoptosis by viral gene productsThe Modulation of Apoptotic Pathways by GammaherpesvirusesComputational discovery of Epstein-Barr virus targeted human genes and signalling pathways.PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein.TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus.Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.The role of viral and bacterial pathogens in gastrointestinal cancer.Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesExpression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1.EBNA-LP associates with cellular proteins including DNA-PK and HA95.Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylationThe Epstein-Barr virus and its association with human cancers.The expression and function of Epstein-Barr virus encoded latent genesEpstein-Barr virus and oncogenesis: from latent genes to tumours.Molecular virology of Epstein-Barr virus.Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia.Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.DNA viruses and viral proteins that interact with PML nuclear bodies.p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathwayDirect interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivationActivation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activationEpstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domainp53 mutation and expression in lymphomaMeta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic locationConstitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.Regulation of the retinoblastoma proteins by the human herpesviruses.Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.
P2860
Q24301537-458DAA32-D870-4A98-9FDB-EB6DB20D2F34Q24336304-D8A310E5-6B70-4FD1-85CA-E7A4935CE6BAQ24531182-9D45897F-E2C1-4A56-8FBA-D184509B4CE3Q24535609-F66AC1FB-0489-4C78-8674-28CF9CF05B22Q24678703-1705E522-E471-4CE6-99E7-DE7CEFADA56EQ26747452-F2FDF0EB-0181-4865-B1DF-B21B226CBD2CQ27321686-EC34D342-0CD6-4838-91CB-CC303CD80B9BQ30486972-EBA8BFE4-4930-4F88-997B-3DB66F9EC869Q30751714-1266FEC0-60A8-4F84-BBD5-C341484D2F0DQ30939262-BE8CE21B-80CC-47BA-B5BF-9D9775218409Q33643988-2360A45B-82BD-4EEC-898F-0EDC434C9330Q33791751-032F3A8D-CE0A-4EB6-801B-1392646FDCE4Q33795078-01445DD6-AF4B-4E0B-ABB0-CCBD163EAAF6Q33836419-0E05FB34-3FE5-4A87-A65C-69A6134CDF1CQ33850943-77C62889-7B2C-479C-8C7A-D95CE95CDF23Q33851767-2BABD12B-5FCE-4069-9970-15C2FF5F42CCQ33882153-D54EA013-6915-423D-9A0E-3CEC2D58AE81Q34089485-7DB4D10C-B4F5-4C9D-9192-BDC0645CB9F0Q34221194-5FE5F60C-853C-4483-80AD-857EC7B7E3D0Q34225554-7A0EF1D7-8021-480A-B396-E041755EC764Q34278271-477AED78-8A3E-4EBF-966B-558F9247F46CQ34291542-5AEFE31A-3070-40DF-96DA-D7758343821AQ34435565-3BC82A5A-9BCE-4319-A01D-C58383D1C1CCQ34972350-41BCEBBF-18C0-456D-84AC-070FF7C96196Q35045601-FD563FD4-2CC1-4C8D-B6B5-EBF7D3D50E6FQ35101216-52EC9461-FB2A-496F-AD07-F955EC8A6608Q35747125-948CAA11-1674-41A4-8657-E227F784B788Q35773554-A8CC0B07-8EEA-4C8A-8E93-4B191793F458Q35789245-B813C9E6-5DF7-405D-96B0-EC2E2C547972Q35835238-5F3157E0-9DD8-4E20-808D-60E489E140DCQ35859223-05B3FF6C-425A-4DC5-8D82-F71813825DE1Q35859250-5EFF8567-F4DC-48AE-BA0B-3837B8D4026BQ35891360-1E89C49C-7F6C-4D67-B29E-C5F3B3A4C294Q35891377-763C5787-841B-41A7-923F-8E8AC483189EQ36081952-50787D1A-BBFA-4C69-B903-8C1CACFAEE95Q36443305-6F323EBA-A008-4671-8217-5FBAE0FC594CQ36574046-253B174C-A02E-4FA0-AEE5-340E93ED7E3CQ36648185-5AA8F2F1-0919-4E6B-9A4B-C07F31946508Q37085853-5C26EB1B-3A65-4FEF-8328-EE51F5D19323Q37227188-B05E5E31-E7CD-464A-8A21-4C1FA8B8F841
P2860
EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
EBNA-5, an Epstein-Barr virus- ...... tinoblastoma and p53 proteins.
@ast
EBNA-5, an Epstein-Barr virus- ...... tinoblastoma and p53 proteins.
@en
type
label
EBNA-5, an Epstein-Barr virus- ...... tinoblastoma and p53 proteins.
@ast
EBNA-5, an Epstein-Barr virus- ...... tinoblastoma and p53 proteins.
@en
prefLabel
EBNA-5, an Epstein-Barr virus- ...... tinoblastoma and p53 proteins.
@ast
EBNA-5, an Epstein-Barr virus- ...... tinoblastoma and p53 proteins.
@en
P2093
P2860
P356
P1476
EBNA-5, an Epstein-Barr virus- ...... etinoblastoma and p53 proteins
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.12.5455
P407
P577
1993-06-01T00:00:00Z